- Home
- HURC vs KZIA Comparison
HURC vs KZIA Comparison
Compare HURC & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HURC | KZIA |
|---|---|---|
| Founded | 1968 | 1994 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.3M | 100.8M |
| IPO Year | 1995 | 2002 |
Fundamental Metrics
Financial Performance| Metric | HURC | KZIA |
|---|---|---|
| Price | $17.05 | $13.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $19.50 |
| AVG Volume (30 Days) | 15.5K | ★ 261.3K |
| Earning Date | 06-05-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $178,554,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.19 | $3.05 |
| 52 Week High | $21.46 | $17.40 |
Technical Indicators
Market Signals| Indicator | HURC | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 67.50 | 74.03 |
| Support Level | $17.07 | $5.85 |
| Resistance Level | $17.94 | $14.42 |
| Average True Range (ATR) | 0.56 | 1.32 |
| MACD | 0.09 | 0.24 |
| Stochastic Oscillator | 93.38 | 91.55 |
Price Performance
Historical ComparisonAbout HURC Hurco Companies Inc.
Hurco Companies Inc is an international industrial technology company that designs, manufactures, and sells computerized (CNC) machine tools for the metal cutting industry through a international sales and distribution network. Its proprietary control systems and software are sold as integral components of its machine tools. The Company also provides machine tool components, automation solutions, software options, upgrades, accessories, replacement parts, and related support services. It operates in the Americas, Europe, and Asia Pacific, with the Americas contributing the majority of revenue. Its core products include vertical and horizontal machining centers (mills), turning centers (lathes), and toolroom machines.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.